• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国结核病预防性治疗接受度的障碍:一项多中心横断面研究

Barriers to the Acceptance of Tuberculosis Preventive Treatment: A Multicenter Cross-sectional Study in China.

作者信息

Ren Jingjuan, Huang Fei, Chen Haifeng, Zhang Huimin, Sun Jianwei, Zhao Ahui, Xu Zuhui, Liu Liqin, Wu Huizhong, Fang Lanjun, Wu Chengguo, Wang Qingya, Zhang Wenqian, Sun Xinhua, Liu Xiaoping, Yuan Jizheng, Chen Bohan, Wang Ni, Zhao Yanlin

机构信息

National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Chinese Center for Disease Control and Prevention, Beijing 102206, China;National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.

Hebei Province Center for Disease Prevention and Control, Hebei 050021, China.

出版信息

Biomed Environ Sci. 2024 Nov 20;37(11):1303-1309. doi: 10.3967/bes2024.150.

DOI:10.3967/bes2024.150
PMID:39667967
Abstract

OBJECTIVE

We aimed to understand the willingness and barriers to the acceptance of tuberculosis (TB) preventive treatment (TPT) among people with latent TB infection (LTBI) in China.

METHODS

A multicenter cross-sectional study was conducted from May 18, 2023 to December 31, 2023 across 10 counties in China. According to a national technical guide, we included healthcare workers, students, teachers, and others occupations aged 15-65 years as our research participants.

RESULTS

Overall, 17.0% (183/1,077) of participants accepted TPT. There were statistically significant differences in the acceptance rate of TPT among different sexes, ages, educational levels, and occupations ( < 0.05). The main barriers to TPT acceptance were misconceptions that it had uncertain effects on prevention (57.8%, 517/894), and concerns about side effects (32.7%, 292/894).

CONCLUSION

An enhanced and comprehensive understanding of LTBI and TPT among people with LTBI is vital to further expand TPT in China. Moreover, targeted policies need to be developed to address barriers faced by different groups of people.

摘要

目的

我们旨在了解中国潜伏性结核感染(LTBI)人群接受结核病(TB)预防性治疗(TPT)的意愿和障碍。

方法

2023年5月18日至2023年12月31日在中国10个县开展了一项多中心横断面研究。根据国家技术指南,我们纳入了年龄在15 - 65岁的医护人员、学生、教师及其他职业人群作为研究参与者。

结果

总体而言,17.0%(183/1077)的参与者接受了TPT。不同性别、年龄、教育水平和职业的TPT接受率存在统计学显著差异(<0.05)。接受TPT的主要障碍是认为其预防效果不确定的误解(57.8%,517/894)以及对副作用的担忧(32.7%,292/894)。

结论

增强LTBI人群对LTBI和TPT的全面了解对于在中国进一步扩大TPT至关重要。此外,需要制定针对性政策以解决不同人群面临的障碍。

相似文献

1
Barriers to the Acceptance of Tuberculosis Preventive Treatment: A Multicenter Cross-sectional Study in China.中国结核病预防性治疗接受度的障碍:一项多中心横断面研究
Biomed Environ Sci. 2024 Nov 20;37(11):1303-1309. doi: 10.3967/bes2024.150.
2
Willingness of receiving preventive treatment and its determinants among individuals with latent tuberculosis infection in Shenzhen, China.中国深圳潜伏性结核感染个体接受预防性治疗的意愿及其决定因素
BMC Infect Dis. 2025 May 4;25(1):651. doi: 10.1186/s12879-025-11026-x.
3
Tuberculosis screening characteristics amongst freshmen in Changping District, Beijing, China.中国北京市昌平区新生结核病筛查特征。
BMC Infect Dis. 2023 Dec 12;23(1):869. doi: 10.1186/s12879-023-08802-y.
4
Facilitators and barriers to initiating and completing tuberculosis preventive treatment among children and adolescents living with HIV in Uganda: a qualitative study of adolescents, caretakers and health workers.乌干达艾滋病毒感染者儿童和青少年启动和完成结核病预防治疗的促进因素和障碍:青少年、照顾者和卫生工作者的定性研究。
AIDS Res Ther. 2024 Aug 29;21(1):59. doi: 10.1186/s12981-024-00643-2.
5
Adherence to preventive treatment for latent tuberculosis infection in close contacts of pulmonary tuberculosis patients: A cluster-randomized controlled trial in China.密切接触肺结核患者的潜伏性结核感染预防治疗的依从性:中国的一项集群随机对照试验。
Int J Infect Dis. 2024 Oct;147:107196. doi: 10.1016/j.ijid.2024.107196. Epub 2024 Jul 27.
6
Factors associated with refusal of preventive therapy after initial willingness to accept treatment among college students with latent tuberculosis infection in Shandong, China.中国山东潜伏性结核感染大学生初始愿意接受治疗后拒绝预防治疗的相关因素。
BMC Infect Dis. 2023 Jan 20;23(1):38. doi: 10.1186/s12879-023-08005-5.
7
Large gap between attitude and action in tuberculosis preventive treatment among tuberculosis-related healthcare workers in eastern China.中国东部地区结核病相关医护人员在结核病预防性治疗方面的态度与行动之间存在较大差距。
Front Cell Infect Microbiol. 2022 Oct 7;12:991400. doi: 10.3389/fcimb.2022.991400. eCollection 2022.
8
[Expert consensus on tuberculosis preventive treatment for individuals at high risk of developing active diseases from latent tuberculosis infection in comprehensive medical facilities].综合医疗机构中潜伏结核感染后发生活动性疾病高危个体的结核病预防性治疗专家共识
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Oct 12;47(10):933-945. doi: 10.3760/cma.j.cn112147-20240328-00173.
9
Facilitators and barriers for tuberculosis preventive treatment among patients with latent tuberculosis infection: a qualitative study.潜伏性结核感染患者中结核预防治疗的促进因素和障碍:一项定性研究。
BMC Infect Dis. 2023 Sep 22;23(1):624. doi: 10.1186/s12879-023-08612-2.
10
The latent tuberculosis cascade-of-care among people living with HIV: A systematic review and meta-analysis.HIV 感染者潜伏性结核病诊疗流程:系统评价和荟萃分析。
PLoS Med. 2021 Sep 7;18(9):e1003703. doi: 10.1371/journal.pmed.1003703. eCollection 2021 Sep.

引用本文的文献

1
Cross-sectional study of preventive treatment for students with latent tuberculosis infection in Shanghai, China.中国上海潜伏性结核感染学生预防性治疗的横断面研究。
BMJ Open Respir Res. 2025 May 11;12(1):e002799. doi: 10.1136/bmjresp-2024-002799.